GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Profound Medical Corp (TSX:PRN) » Definitions » Cyclically Adjusted PB Ratio

Profound Medical (TSX:PRN) Cyclically Adjusted PB Ratio : 1.92 (As of Jun. 02, 2025)


View and export this data going back to 2014. Start your Free Trial

What is Profound Medical Cyclically Adjusted PB Ratio?

As of today (2025-06-02), Profound Medical's current share price is C$7.21. Profound Medical's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was C$3.75. Profound Medical's Cyclically Adjusted PB Ratio for today is 1.92.

The historical rank and industry rank for Profound Medical's Cyclically Adjusted PB Ratio or its related term are showing as below:

TSX:PRN' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.71   Med: 2.6   Max: 3.63
Current: 1.92

During the past years, Profound Medical's highest Cyclically Adjusted PB Ratio was 3.63. The lowest was 1.71. And the median was 2.60.

TSX:PRN's Cyclically Adjusted PB Ratio is ranked worse than
51.31% of 497 companies
in the Medical Devices & Instruments industry
Industry Median: 1.87 vs TSX:PRN: 1.92

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Profound Medical's adjusted book value per share data for the three months ended in Mar. 2025 was C$2.426. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is C$3.75 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Profound Medical Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Profound Medical's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Profound Medical Cyclically Adjusted PB Ratio Chart

Profound Medical Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 2.80

Profound Medical Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 2.76 2.68 2.80 2.19

Competitive Comparison of Profound Medical's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, Profound Medical's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Profound Medical's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Profound Medical's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Profound Medical's Cyclically Adjusted PB Ratio falls into.


;
;

Profound Medical Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Profound Medical's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=7.21/3.75
=1.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Profound Medical's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Profound Medical's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=2.426/129.1809*129.1809
=2.426

Current CPI (Mar. 2025) = 129.1809.

Profound Medical Quarterly Data

Book Value per Share CPI Adj_Book
201506 4.885 100.500 6.279
201509 4.170 100.421 5.364
201512 3.496 99.947 4.519
201603 2.668 101.054 3.411
201606 1.729 102.002 2.190
201609 0.737 101.765 0.936
201612 2.662 101.449 3.390
201703 1.965 102.634 2.473
201706 1.222 103.029 1.532
201709 2.488 103.345 3.110
201712 1.964 103.345 2.455
201803 3.873 105.004 4.765
201806 3.326 105.557 4.070
201809 2.905 105.636 3.552
201812 2.431 105.399 2.980
201903 2.214 106.979 2.673
201906 1.725 107.690 2.069
201909 1.966 107.611 2.360
201912 1.597 107.769 1.914
202003 4.603 107.927 5.509
202006 4.273 108.401 5.092
202009 6.271 108.164 7.489
202012 6.170 108.559 7.342
202103 5.774 110.298 6.763
202106 5.389 111.720 6.231
202109 5.370 112.905 6.144
202112 4.967 113.774 5.640
202203 4.537 117.646 4.982
202206 4.168 120.806 4.457
202209 3.841 120.648 4.113
202212 3.384 120.964 3.614
202303 3.158 122.702 3.325
202306 2.772 124.203 2.883
202309 2.442 125.230 2.519
202312 1.960 125.072 2.024
202403 2.541 126.258 2.600
202406 2.197 127.522 2.226
202409 1.706 127.285 1.731
202412 2.866 127.364 2.907
202503 2.426 129.181 2.426

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Profound Medical  (TSX:PRN) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Profound Medical Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Profound Medical's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Profound Medical Business Description

Traded in Other Exchanges
Address
2400 Skymark Avenue, Unit 6, Mississauga, ON, CAN, L4W 5K5
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
Executives
Arthur Lee Rosenthal Director
Dr. Arun Menawat Director, Senior Officer
Thomas Michael Tamberrino Senior Officer
Rashed Osman Dewan Senior Officer
Abbey Klair Goodman Senior Officer
Murielle Lortie Director
Cynthia Ann Lavoie Director
Brian Ellacott Director
Aaron Davidson Senior Officer
Guruprit Kour Singh Senior Officer
Ian Heynen Senior Officer

Profound Medical Headlines